Therapy and prognosis of several solid and hematologic malignancies, including non-small cell lung cancer (NSCLC), have been favourably impacted by the introduction of immune checkpoint inhibitors (ICIs). Their mechanism of action relies on the principle that some cancers can evade immune surveillance by expressing surface inhibitor molecules, known as "immune checkpoints". ICIs aim to conceal tumoral checkpoints on the cell surface and reinvigorate the ability of the host immune system to recognize tumour cells, triggering an antitumoral immune response.In this review, we will focus on the imaging patterns of different responses occurring in patients treated by ICIs. We will also discuss imaging findings of immune-related adverse events (irAEs), along with current and future perspectives of metabolic imaging. Finally, we will explore the role of radiomics in the setting of ICI-treated patients.

The radiological appearances of lung cancer treated with immunotherapy: a review / Milanese, Gianluca; Mazzaschi, Giulia; Ledda, Roberta Eufrasia; Balbi, Maurizio; Lamorte, Sveva; Caminiti, Caterina; Colombi, Davide; Tiseo, Marcello; Silva, Mario; Sverzellati, Nicola. - In: BRITISH JOURNAL OF RADIOLOGY. - ISSN 0007-1285. - (2022). [10.1259/bjr.20210270]

The radiological appearances of lung cancer treated with immunotherapy: a review

Milanese, Gianluca;Mazzaschi, Giulia;Ledda, Roberta Eufrasia;Balbi, Maurizio;Lamorte, Sveva;Caminiti, Caterina;Colombi, Davide;Tiseo, Marcello;Silva, Mario;Sverzellati, Nicola
2022-01-01

Abstract

Therapy and prognosis of several solid and hematologic malignancies, including non-small cell lung cancer (NSCLC), have been favourably impacted by the introduction of immune checkpoint inhibitors (ICIs). Their mechanism of action relies on the principle that some cancers can evade immune surveillance by expressing surface inhibitor molecules, known as "immune checkpoints". ICIs aim to conceal tumoral checkpoints on the cell surface and reinvigorate the ability of the host immune system to recognize tumour cells, triggering an antitumoral immune response.In this review, we will focus on the imaging patterns of different responses occurring in patients treated by ICIs. We will also discuss imaging findings of immune-related adverse events (irAEs), along with current and future perspectives of metabolic imaging. Finally, we will explore the role of radiomics in the setting of ICI-treated patients.
2022
The radiological appearances of lung cancer treated with immunotherapy: a review / Milanese, Gianluca; Mazzaschi, Giulia; Ledda, Roberta Eufrasia; Balbi, Maurizio; Lamorte, Sveva; Caminiti, Caterina; Colombi, Davide; Tiseo, Marcello; Silva, Mario; Sverzellati, Nicola. - In: BRITISH JOURNAL OF RADIOLOGY. - ISSN 0007-1285. - (2022). [10.1259/bjr.20210270]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2934177
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact